- Date de réalisation : 10 Novembre 2015
- Durée du programme : 21 min
- Classification Dewey : Cancer
- Auteur(s) : RONDEAU Virginie
- producteur : Université de Bordeaux - Service Audiovisuel et Multimédia
- Réalisateur(s) : Université de Bordeaux - Service Audiovisuel et Multimédia
- Editeur : Université de Bordeaux - Service Audiovisuel et Multimédia
Dans la même collectionFlash talk - Call for proposal FAC 2014 A new weapon against the tobacco industry : class action lawsuit using a novel epidemiologic ... From the OR to clinical database... what for ? The example of UroCCR A combined laser microdissection and mass spectrometry method for proteomic analysis of tissue ... Experts panel discussion: What opportunities and best practices for the use of clinical material in ... BRIO strategic challenges and the implementation of a translational culture in Bordeaux
Modelling prognostic capabilities of tumor size : application to colorectal cancer
Epidemiology and public health
In oncology, the international WHO and RECIST criteria have allowed the standardization of tumor response evaluation in order to identify the time of disease progression. These semi-quantitative measurements are often used as endpoints in phase II and phase III trials to study the efficacy of new therapies. However, through categorization of the continuous tumor size, information can be lost and they can be challenged by recently developed methods of modeling biomarkers in a longitudinal way. Thus, it is of interest to compare the predictive ability of cancer progressions based on categorical criteria and quantitative measures of tumor size (left-censored due to detection limit problems) and/or appearance of new lesions on overall survival. We propose a joint model for a simultaneous analysis of three types of data: longitudinal marker, recurrent events and a terminal event. A simulation study is performed and shows that the proposed trivariate model is appropriate for the practical use. We suggest statistical tools that evaluate predictive accuracy for joint models to compare our model to models based on categorical criteria and their components. We apply the model to a randomized phase III clinical trial of metastatic colorectal cancer, conducted by the Fédération Francophone de Cancérologie Digestive (FFCD 2000-05 trial), which assigned 410 patients to two therapeutic strategies with multiple successive chemotherapy regimens.
Cette présentation a été donnée dans le cadre du BRIO SIRIC scientific day 3 organisé annuellement par le SIRIC BRIO et qui a pour but de réunir tous les acteurs du SIRIC BRIO et plus largement de la cancérologie à Bordeaux.